Leading Commercial Strategy and Growth in MedTech With Chris Reese

Chris Reese is the Senior Vice President of Sales at NeuroPace, a medical device company dedicated to improving the lives of people with drug-resistant epilepsy through advanced neurostimulation technology. With nearly two decades of leadership experience, Chris has played key commercial roles at leading medtech companies — including driving over $800 million in value during Vertiflex's acquisition by Boston Scientific and leading US sales for the ENT business at Medtronic. A former US Marine, he brings a unique blend of military discipline, startup grit, and Fortune 500 expertise to his work, making him an influential mentor and champion for developing future medical sales professionals.

In this episode…

In highly regulated industries like medtech, growth rarely comes from moving fast and cutting corners. It comes from earning trust, aligning teams, and making smart decisions when the stakes are high, but what does that really look like in practice?

For Chris Reese, a sales leader in the medical device industry, the answer starts with people. He believes that sustainable growth happens when teams are aligned around purpose, patient impact, and mutual accountability. Chris shares how strong relationships, healthy tension across functions, and leaders who show up consistently create the conditions where both people and performance can thrive.

In this episode of In Good Company: Where Relationships Drive Results, Lisa Kilrea is joined by Chris Reese, Senior Vice President of Sales at NeuroPace, to discuss leading commercial strategy and growth in medtech. They explore navigating regulation without losing momentum, building trust across sales, marketing, and clinical teams, and developing leaders who balance empathy with high standards.